Salem Investment Counselors’s Apyx Medical APYX Stock Holding History

Salem Investment Counselors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-45,500	Closed	-$168K	–	1249
2026 Q1	$168K	Hold	45,500	–	–	﹤0.01%	408
2025 Q4	$159K	Hold	45,500	–	–	﹤0.01%	382
2025 Q3	$97.4K	Buy	+45,500	New	+$96.3K	﹤0.01%	469
2024 Q2	–	Sell	-19,630	Closed	-$26.7K	–	1168
2024 Q1	$26.7K	Sell	19,630 -1,880	-9%	-$4K	﹤0.01%	668
2023 Q4	$56.4K	Hold	21,510	–	–	﹤0.01%	519
2023 Q3	$68.8K	Hold	21,510	–	–	﹤0.01%	476
2023 Q2	$108K	Hold	21,510	–	–	﹤0.01%	404
2023 Q1	$61.9K	Hold	21,510	–	–	﹤0.01%	495
2022 Q4	$50.3K	Hold	21,510	–	–	﹤0.01%	514
2022 Q3	$97K	Buy	21,510 +2,000	+10%	+$14.3K	﹤0.01%	395
2022 Q2	$114K	Buy	19,510 +1,000	+5%	+$5.13K	0.01%	398
2022 Q1	$121K	Buy	18,510 +1,500	+9%	+$14.8K	﹤0.01%	395
2021 Q4	$218K	Sell	17,010 -500	-3%	-$6.99K	0.01%	360
2021 Q3	$243K	Sell	17,510 -6,000	-26%	-$63.1K	0.01%	318
2021 Q2	$242K	Sell	23,510 -17,047	-42%	-$169K	0.01%	303
2021 Q1	$392K	Hold	40,557	–	–	0.02%	233
2020 Q4	$292K	Hold	40,557	–	–	0.02%	248
2020 Q3	$191K	Hold	40,557	–	–	0.01%	248
2020 Q2	$225K	Hold	40,557	–	–	0.02%	229
2020 Q1	$146K	Hold	40,557	–	–	0.02%	252
2019 Q4	$343K	Hold	40,557	–	–	0.03%	215
2019 Q3	$275K	Hold	40,557	–	–	0.03%	223
2019 Q2	$273K	Sell	40,557 -20,200	-33%	-$110K	0.03%	230
2019 Q1	$431K	Hold	60,757	–	–	0.04%	164
2018 Q4	$394K	Hold	60,757	–	–	0.05%	154
2018 Q3	$431K	Hold	60,757	–	–	0.04%	164
2018 Q2	$264K	Hold	60,757	–	–	0.02%	183
2018 Q1	$178K	Hold	60,757	–	–	0.02%	193
2017 Q4	$158K	Buy	60,757 +30,986	+104%	+$96.7K	0.02%	208
2017 Q3	$109K	Hold	29,771	–	–	0.01%	232
2017 Q2	$74K	Hold	29,771	–	–	0.01%	268
2017 Q1	$80K	Buy	+29,771	New	+$98.9K	0.01%	325
2016 Q4	–	Sell	-29,771	Closed	-$1.55K	–	676
2016 Q3	$1.55K	Hold	29,771	–	–	0.02%	230
2016 Q2	$49K	Buy	29,771 +17,047	+134%	+$29.6K	0.01%	253
2016 Q1	$21K	Hold	12,724	–	–	﹤0.01%	251
2015 Q4	$27K	Buy	+12,724	New	+$24.6K	﹤0.01%	258

Other funds holding APYX

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

ZCP

Z3 Capital Partners Richmond, Virginia $476M AUM

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return

TCOT

Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Salem Investment Counselors's APYX Position: Q2 2026 in Review

Salem Investment Counselors sold out of Apyx Medical (APYX) in Q2 2026, closing a stake of 45,500 shares — an estimated $168K sold.

Salem Investment Counselors first reported a position in APYX in Q4 2015 and held it in 36 quarters. The position peaked at $431K in Q1 2019. 8 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

Salem Investment Counselors reported no remaining Apyx Medical position as of Q2 2026 after selling out during the quarter.
Salem Investment Counselors sold 45,500 Apyx Medical shares in Q2 2026, an estimated $168K.
Salem Investment Counselors first reported a position in Apyx Medical in Q4 2015 and held it in 36 quarters.
Salem Investment Counselors's Apyx Medical position peaked at $431K in Q1 2019.
8 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.